Search

everythinglearnresearchcommunity

for

Search:↓

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

The drug combination was safe and showed promise in treating advanced tumors.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Nilotinib can cause keratosis pilaris, a skin condition.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Upadacitinib effectively treats pyoderma gangrenosum.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

MK-5108 is safe and shows potential against tumors, especially alone.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

Ruxolitinib treatment may cause eyelash growth.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

TAK-279 effectively reduces psoriasis symptoms and is safe.